Growth inhibitory effects of large subunit ribosomal proteins in melanoma

Gregory R. Kardos, Mu Shui Dai, Gavin P. Robertson

Research output: Contribution to journalArticlepeer-review

17 Scopus citations


Ribosome biogenesis can modulate protein synthesis, a process heavily relied upon for cancer cell proliferation. In this study, involvement of large subunit ribosomal proteins (RPLs) in melanoma has been dissected and RPLs categorized based on modulation of cell proliferation and therapeutic targeting potential. Based on these results, two categories of RPLs were identified: the first causing negligible effects on cell viability, p53 expression, and protein translation, while the second category decreased cell viability and inhibited protein synthesis mediated with or without p53 protein stabilization. RPL13 represents the second category, where siRNA-mediated targeting inhibited tumor development through decreased cellular proliferation. Mechanistically, decreased RPL13 levels increased p53 stability mediated by RPL5 and RPL11 binding to and preventing MDM2 from targeting p53 for degradation. The consequence was p53-dependent cell cycle arrest and decreased protein translation. Thus, targeting certain category 2 RPL proteins can inhibit melanoma tumor development mediated through the MDM2-p53 pathway.

Original languageEnglish (US)
Pages (from-to)801-812
Number of pages12
JournalPigment Cell and Melanoma Research
Issue number5
StatePublished - 2014

All Science Journal Classification (ASJC) codes

  • Oncology
  • General Biochemistry, Genetics and Molecular Biology
  • Dermatology


Dive into the research topics of 'Growth inhibitory effects of large subunit ribosomal proteins in melanoma'. Together they form a unique fingerprint.

Cite this